New NASDAQ Report on a Company we Have Never Featured Before. Coming Monday August 2nd, 2021 at Market Open. Details and Market Update Inside.

New NASDAQ Report on a Company we Have Never Featured Before. Coming Monday August 2nd, 2021 at Market Open. Details and Market Update Inside.

Our Good Economy Looks Like It Will Hang Around for a While

This is a NASDAQ MedTech Company with a Low Float and Exciting Potential Catalysts’ Ahead. Read the full report below for more about this new featured NASDAQ report.

Good day and welcome to all our new group members,

Remember to always be sure your subscribed to both TEXT and EMAIL alerts to ensure delivery. Text the keyword “Traders” to 25827 or click here and enter your mobile number. Note* We will soon be switching to 52736 as our dedicated short code number. No changes are required on your part, you will be automatically moved over.

The U.S. Bureau of Economic Analysis released its advanced estimate of Q2 GDP Thursday morning. The headline we read spoke of how the Q2 data missed analysts’ expectations. We would offer a slightly different headline:

“The American Economy Appears Strong”

Q2 GDP, seasonally adjusted annualized rate: 6.5%.
Personal consumption rose: 11.8%
Core personal consumption, QoQ: 6.0%

These are great economic data for the US economy. Some analysts say we are at the peak of expansion and to expect a contraction for the rest of the year. A mild dip from the numbers above may still indicate a good economy.

Consumers have gotten stimulus checks and unemployment supplement payments. Now there are up to $300 per child payments going to many Americans and congress is negotiating a $1T economic stimulus package. All this money is going to be pumped into the economy, so we don’t see a serious downturn in the immediate future.

We have an upcoming report that has us excited. The report will cover a NASDAQ MedTech company that we’ve never reported on and is working on advanced medicine. As medical science presents remarkable advances in the ways we look at treating disease, this company is leading the way.

Not only is this company developing its own curative platforms, but it’s also helping other companies advance theirs. We all like to imagine there are companies out there working on MedTech that is disruptive and so advanced as to leave us bewildered. This will be one of those companies.

We think you might also like some of the metrics associated with this company. Small share structure, low share price and market cap, a high level of insider ownership and generating revenues. There’s more, the company shares are trading 40% off their recent high and the chart indicates a potential swing to the upside.

Stay tuned and stay informed.
The Traders News Group